Gossamer Bio financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

고사머 바이오NASDAQ:GOSS · Nasdaq · Healthcare

$10.71-2.01%

2026-10-02 close

Gossamer Bio's published financial data is dated 2026-10-04. 2024 revenue was $115M. 2024 operating profit was −$60M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy